← Back to Search

Bright Light Therapy Support for Depression

N/A
Waitlist Available
Led By Greg Clarke, PhD
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
New episode of unipolar depression within the last month, defined as: New ICD-10 diagnosis of SAD or unipolar depression (i.e., major depression, minor depression, depression not otherwise specified, and/or adjustment disorder with depressed mood) AND usual care administration of the PHQ-9 depression scale in the last 30 days, with a total score of 10 or higher
Age 18-69 years, inclusive
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through follow-up at 2, 4 and 6 months post-enrollment
Awards & highlights

Study Summary

This trial is testing whether giving people written educational material or phone coaching assistance for Bright Light Therapy (BLT) initiation and adherence leads to better outcomes than not giving any assistance.

Who is the study for?
The Bright Start Study is for adults aged 18-69 with a new episode of unipolar depression diagnosed within the last month, as indicated by certain criteria including a PHQ-9 score of 10 or higher. Participants must have internet access and be able to engage in English-language coaching.Check my eligibility
What is being tested?
This study tests three methods of delivering Bright Light Therapy (BLT) to patients: usual care without BLT assistance; written educational material on BLT; and written material plus phone coaching for BLT adherence. It's a pilot trial not meant for definitive conclusions but to prepare for future research.See study design
What are the potential side effects?
While side effects are not detailed, potential risks may include skin or eye sensitivity due to light exposure, especially if participants have pre-existing conditions like cataracts or take photosensitizing medications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with depression recently and scored 10 or higher on the PHQ-9.
Select...
I am between 18 and 69 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through follow-up at 2, 4 and 6 months post-enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through follow-up at 2, 4 and 6 months post-enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Health Questionnaire-9 (PHQ-9)
Secondary outcome measures
Pittsburgh Sleep Quality Index (PSQI)
Quick Inventory of Depressive Symptomatology, self-report (QIDS-SR)

Trial Design

3Treatment groups
Active Control
Group I: Treatment as Usual (TAU)Active Control1 Intervention
"Usual care services" control group
Group II: Minimal BLT EncouragementActive Control1 Intervention
Two minimal written communications promoting BLT as a promising treatment and outlining steps for patients to self-initiate. Arm 2 will not include any phone coaching or adherence promotion.
Group III: Enhanced BLT Encouragement + Adherence PromotionActive Control2 Interventions
2-4 brief calls to encourage BLT use, advise on purchase of a light box (LB), assist with obtaining compensation for LB purchase, educate for correct LB use, and provide motivational interviewing (MI) as needed to promote adherence. Arm 3 participants will also receive the written educational material on BLT.

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
538 Previous Clinical Trials
24,113,698 Total Patients Enrolled
35 Trials studying Depression
120,794 Patients Enrolled for Depression
Greg Clarke, PhDPrincipal InvestigatorKaiser Permanente
1 Previous Clinical Trials
488 Total Patients Enrolled

Media Library

Minimal BLT Encouragement Clinical Trial Eligibility Overview. Trial Name: NCT05356130 — N/A
Depression Research Study Groups: Treatment as Usual (TAU), Minimal BLT Encouragement, Enhanced BLT Encouragement + Adherence Promotion
Depression Clinical Trial 2023: Minimal BLT Encouragement Highlights & Side Effects. Trial Name: NCT05356130 — N/A
Minimal BLT Encouragement 2023 Treatment Timeline for Medical Study. Trial Name: NCT05356130 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom does this research opportunity extend?

"This medical trial seeks to recruit 90 individuals suffering from depression, aged between 18 and 69. To be eligible for this study, applicants must meet the following requirements: Be within the aforesaid age range; Exhibit symptoms of unipolar depression in accordance with ICD-10 standards that have arisen within a month prior to application; Possess an active MyChart account associated with kp.org and demonstrate use in recent months; Have both phone as well as internet access along with linguistic proficiency (English); Demonstrate willingness to partake in assessments related to the experiment & receive coaching over telephone calls."

Answered by AI

Has recruitment of participants commenced in this clinical trial?

"Per information sourced from clinicaltrials.gov, this trial is no longer taking in participants; its initial posting was on February 17th 2022 and the most recent update occurred on May 23rd 2022. In spite of that, 1133 other studies are recruiting individuals as we speak."

Answered by AI

Is this investigation open to geriatric participants?

"Eligibility criteria for this trial necessitates that participants are at least 18 years of age and no older than 69."

Answered by AI

Who else is applying?

What state do they live in?
Washington
How old are they?
18 - 65
What site did they apply to?
Kaiser Permanente Northwest Center for Health Research
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Bright Start Study
2022. "Bright Start Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05356130.
~28 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top